Home
Services
Organic Synthesis
Peptide Synthesis
Antibody Production
Protein Expression
Bioconjugation Service
Immunoassay Service
Molecular Biology Services
Oligonucleotides Synthesis
RNA Synthesis Service
Polymers & Contract Manufacturing
cGMP Peptide Synthesis Services
cGMP Organic Synthesis Services
Products
Small Molecule Inhibitors and Antagonist
Bioactive Compounds and Agonist
Primary Antibodies
Catalog Peptides
Amino Acids Derivatives
Reagents
Fluorescent dyes
Intermediates
PCR
Proteasomes and Enzymes
Enzyme substrate
Nucleotides
Promotions
Customer Support
About Us
Site Map
Contact Us
Primary Antibodies
Adhesion
Cancer/Apoptosis
Cell Cycle
Channel
Cleaved-specific
Cytoskeletal
GPCR
Growth Factors
GTP-binding
Homeobox
Intermediate Domains
Lymphocyte Signaling
Neuroscience
Phosphatases/Kinases
Phospho-specific
Receptors
Transcription
Translation
Transporters
Cat. No. Name Size Price Add Cart
KA4867 eIF2B (Ab-67) Antibody Quote Quote

Overview

Product NameeIF2B (Ab-67) Antibody
ApplicationsWB, ELISA
ConcentrationRabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
ImmunogenThe antiserum was produced against synthesized peptide derived from N-terminal of human eIF2B.
Specificity/SensitivityeIF2B (Ab-67) antibody detects endogenous levels of total eIF2B protein.

Product Information

SourceRabbit
Research AreasIntermediates
Alternative NamesDKFZp686L18198; eIF-2-beta; EIF2; EIF2B; EIF2beta; EIF2S2; eukaryotic initiation factor 2-beta; eukaryotic translation initiation factor 2 beta; Eukaryotic translation initiation factor 2 subunit 2; Eukaryotic translation initiation factor 2 subunit beta; eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa; IF2B; MGC8508
Storage/StabilityStore at -20/1 year
ClonalityPolyclonal
PurificationThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Species ReactivityHuman; Mouse
Application NotesWB: 1:500~1:3000 ELISA: 1:40000
WB
Western blot analysis of extracts from K562 cells, using eIF2B (Ab-67) antibody. The lane on the right is treated with the synthesized peptide.

Western blot analysis of extracts from JK cells (Lane 2), using eIF2B (Ab-67) Antibody. The lane on the left is treated with systhesized peptide.
ReferencesPathak V.K., Cell 54:633-639(1988). Deloukas P., Nature 414:865-871(2001). Olsen J.V., Cell 127:635-648(2006).
Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.
About
KareBayTM Biochem
Sitemap
Blog
Custom Services
Organic Synthesis
Peptide Synthesis
Antibody Production
Protein Expression
Bioconjugation Service
Immunoassry Service
Molecular Biology Services
Oligonucleotides Synthesis
RNA Synthesis Service
cGMP Peptide Synthesis Services
cGMP Organic Synthesis Services
Biochemical Products
Small Molecule Inhibitors
Bioactive Compounds
Primary Antibodies
Peptides
Amino Acids
Reagents
Fluorescent dyes
Intermediates
PCR
Contact Us
KareBayTM Biochem, Inc.
11 Deer Park Drive, Suite 102A
Monmouth Junction, NJ 08852
Telephone
: 732-823-1545

Fax
: 732-823-1349
product@karebaybio.com
service@karebaybio.com
support@karebaybio.com
Follow Us
Follow Karebay on LinkedinFollow IMAGING on Twitter Google+ Facebook